EntheoTech Bioscience, a Canadian bioscience company specializing in psychedelic-assisted therapy (PAT), has opened its flagship clinic in Kelowna, British Columbia. The clinic aims to combine the use of psychedelics with therapy to provide a unique treatment experience for individuals with mental health conditions. Additional clinics are planned to open in Vancouver, Calgary, and Edmonton later this year.
EntheoMed, the brand under which the clinics operate, offers intramuscular ketamine-assisted therapy. The therapy is administered by a team of healthcare professionals, including physicians, nurses, psychotherapists, and psychedelic facilitators.
EntheoTech focuses on research and development of natural psilocybin formulas to address chronic pain, mental health conditions, and opioid overuse. Their mission is to provide access to PAT and integrative treatments for depression, anxiety, chronic pain, and PTSD using Health Canada-approved substances like ketamine, psilocybin, and MDMA. The company aims to provide integrative wellness experiences that combine traditional and new medicines.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.